SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Exome sequencing and CRISPR/Cas genome editing identify mutations of ZAK as a cause of limb defects in humans and mice.
|
26755636 |
2016 |
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Exome sequencing and CRISPR/Cas genome editing identify mutations of ZAK as a cause of limb defects in humans and mice.
|
26755636 |
2016 |
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Congenital Fiber Type Disproportion
|
0.510 |
GeneticVariation
|
disease |
BEFREE |
Recessive mutations in the kinase ZAK cause a congenital myopathy with fibre type disproportion.
|
27816943 |
2017 |
Congenital Fiber Type Disproportion
|
0.510 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Recessive mutations in the kinase ZAK cause a congenital myopathy with fibre type disproportion.
|
27816943 |
2017 |
Congenital Fiber Type Disproportion
|
0.510 |
GermlineCausalMutation
|
disease |
ORPHANET |
Recessive mutations in the kinase ZAK cause a congenital myopathy with fibre type disproportion.
|
27816943 |
2017 |
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION
|
0.400 |
GeneticVariation
|
disease |
UNIPROT |
Autozygome and high throughput confirmation of disease genes candidacy.
|
30237576 |
2019 |
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION
|
0.400 |
GeneticVariation
|
disease |
UNIPROT |
Recessive mutations in the kinase ZAK cause a congenital myopathy with fibre type disproportion.
|
27816943 |
2017 |
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Ectrodactyly
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Carcinoma of lung
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
We identified six significant lung cancer risk-associated SNPs in two genes (CSNK2B and ZAK) after correction for multiple comparisons by a false discovery rate (FDR) <0.20.
|
29071797 |
2018 |
Carcinoma of lung
|
0.130 |
GeneticVariation
|
disease |
GWASCAT |
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.
|
28604730 |
2017 |
Carcinoma of lung
|
0.130 |
AlteredExpression
|
disease |
BEFREE |
In keeping with previous observations, we find that Notch3 in particular is upregulated in human lung cancer lines and that downregulation of Notch signaling using a selective γ-secretase inhibitor (MRK-003) is associated with decreased proliferation and clonogenic capacity in vitro.
|
21994468 |
2011 |
Carcinoma of lung
|
0.130 |
Biomarker
|
disease |
BEFREE |
In this study, we determined the ability of MRK-003, a gamma-secretase inhibitor, to inhibit Notch3 signaling, growth, and apoptosis of lung cancer cell lines in vitro and in vivo using mouse xenograft models.
|
17804716 |
2007 |
Smoking
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences.
|
30643258 |
2019 |
Diastolic blood pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits.
|
30224653 |
2018 |
mathematical ability
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals.
|
30038396 |
2018 |
Blepharoptosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cardiomyopathy, Dilated
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Congenital clubfoot
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cryptorchidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Failure to Thrive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital pectus excavatum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|